UNSPSC 51295108: Fantridone hydrochloride

This classification denotes an antidepressant agent with the molecular formula C18H20N2O.CLH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DU65LYP662. The term fantridone hydrochloride is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule fantridone hydrochloride under HS 29337900 and SITC 51561. As of Q4 2014, FANTRIDONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Fantridone hydrochloride bears US NLM identifiers UMLS ID C1880733 and NCI Concept Code C65619.

SMILES: CN(C)CCCN1C2CCCCC2C3CCCCC3C1=O.O.CL.

UNSPSC 51295108 Fantridone hydrochloride is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and drug-related supplies acquired for public health and community health initiatives. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS—does not name fantridone explicitly; instead, the county solicited naloxone and safe drug deactivation systems for community health support. The code's nominal scope (a specific pharmaceutical compound) and the actual procurement activity show a material mismatch. State and local governments appear to use this code when acquiring pharmaceutical supplies and drug-related products for public health programs, though the recent record does not confirm active or frequent procurement of fantridone itself under this code.

Seminole County, Florida represents the only recent issuing body in the available record. The county posted IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023 (a date inconsistent with the posting date and likely a data error in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems on an annual basis with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with a one-year renewal option, E-Verify and drug-free workplace requirements, and potential FEMA funding with corresponding federal compliance obligations. The source provides no evidence of comparable recent opportunities under this code in other jurisdictions or states, limiting assessment of geographic spread or issuing-body concentration.